Overview
Financials
Revenue history
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 1210 days for 2021). All were audited by a statutory auditor.
- 2022not filed
- 202106/11/2025
- 202017/11/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2021.
Results vs industry
Industry
Public procurement
20 tenders recorded as contractor: 9 national ($162,839) and 11 EU ($47,540).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 29, 2026 | 82.2026 Supply of small laboratory equipment for the organisational units of Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu | $897$897 | Uniwersytet Medyczny Im. Piastów Śląskich we Wrocławiu | |
| Jun 10, 2026 | Supply of reagents for cell biology | $235$235 | Instytut Medycyny Doświadczalnej i Klinicznej Im. Mirosława Mossakowskiego Pan | |
| May 27, 2026 | Sale and delivery of chemical reagents | $1,047$1,047 | Uniwersytet Rzeszowski |
Trademarks
Medianus Pharma holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2020.
| Mark | Protected until | |
|---|---|---|
| Canntabiol | May 28, 2030 |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the company is represented by the President of the Management Board independently, or by a member of the management board acting jointly with the President of the Management Board.
Supervisory board
Ownership
| Owner | Share value | Stake |
|---|---|---|
Paweł Błachutage 59 | $27,012.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-04-21.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 24, 2025 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Eclipse Boluk-Sobolewskasp. k. | $10,235,697.61 | eclipsemedical.pl | ||
| Passimedsp. z o.o. | $1,677,642.39 | passimed.pl | ||
| Medimessp. z o.o. | $1,228,073.80 | medimes.pl | ||
| Model MedicalS.A. | $754,014.76 | modelmedical.pl | ||
| Interforum Pharmasp. z o.o. | $710,214.55 | interforumpharma.com | ||
| Softmedicasp. z o.o. | $481,553.31 | softmedica.com.pl | ||
| Eduaidsp. z o.o. | $22,952.22 | eduaid.pl | ||
| Beyond Medical Aesthetics Polskasp. z o.o. | $13,696.94 | bmapolska.pl | ||
| Model Medical Radiologiasp. z o.o. | – | modelmedical.pl | ||
| Focusmed Sp.Z O.O.sp. z o.o. | – | focusmed.pl |
FAQ
Last updated: 2026-04-22